Kazakhstan vs Sudan: The number of people with susceptibility test result for rifampicin
Kazakhstan
5,121
in 2021
Sudan
6,193
in 2021
Kazakhstan rank
28th
Sudan rank
27th
The number of people with susceptibility test result for rifampicin over time
- Kazakhstan
- Sudan
How they compare
Sudan currently reports 6,193 against 5,121 in Kazakhstan, a difference of 1,072.
That makes Sudan's figure about 1.2 times Kazakhstan's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Kazakhstan ahead.
Kazakhstan ranks 28th and Sudan ranks 27th of 155 countries.
Across the 2 decades both report, Kazakhstan averaged higher in 1 and Sudan in 1.
Head to head by decade
| Decade | Kazakhstan | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5,272 | 1,894 | 3,378 | Kazakhstan |
| 2020s | 4,990 | 5,498 | 509 | Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Kazakhstan or Sudan?
- Sudan, at 6,193 against 5,121 in Kazakhstan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Kazakhstan and Sudan?
- 1,072, with Sudan ahead.
- How many years of comparable data are there for Kazakhstan and Sudan?
- 5 years are reported by both, from 2017 to 2021.
- How do Kazakhstan and Sudan rank globally for the number of people with susceptibility test result for rifampicin?
- Kazakhstan ranks 28th and Sudan ranks 27th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.